Remedy Pharmaceuticals, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Remedy Pharmaceuticals, Inc.
Quantité totale PI 58
Rang # Quantité totale PI 24 069
Note d'activité PI 2,5/5.0    38
Rang # Activité PI 19 658

Brevets

Marques

38 0
12 0
8 0
0
 
Dernier brevet 2025 - Methods of treating ischemic str...
Premier brevet 2007 - Treatment of alzheimer's disease...

Derniers inventions, produits et services

2025 Invention Methods of treating ischemic stroke at risk for cerebral or cerebellar edema. The invention rela...
Invention Low-sorbing glyburide formulation and methods. Methods and formulations for minimizing or avoidi...
Invention Methods of treating ischemic stroke at risk for cerebral or cerebellar edema. This disclosure re...
Invention Methods of treating ischemic stroke at risk for cerebral or cerebellar edema using a sur1-trpm4 c...
Invention Methods of treating ischemic stroke at risk for cerebral or cerebellar edema. The invention relat...
Invention Methods of treating ischemic stroke with large vessel occlusion using a sur1-trpm4 channel inhibi...
Invention Methods of treating ischemic stroke at risk for cerebral or cerebellar edema. 3 as measured by MR...
Invention Methods of medical treatment with sur1-trpm4 channel inhibitors. A method of treating or prevent...
Invention Methods of intravenous administration of glyburide. The present disclosure is drawn to a method ...
2024 Invention Methods of treating injuries or conditions related to cns edema. The present technology is relat...
2023 Invention Low-sorbing glyburide kit, formulation and methods. The disclosure relates to compositions and m...
Invention Methods of intravenous administration of glyburide. The present disclosure is drawn to a method o...
2021 Invention Methods of treating injuries or conditions related to cns edema. The present technology is relate...
2020 Invention Formulations and methods for lyophilization and lyophilates provided thereby. The present invent...
Invention Composition containing glibenclamide. NSC antagonists are disclosed as useful in the treatment o...
Invention Method for treating subjects suffering from central nervous system contusions. Methods of inhibi...
2019 Invention Composition containing glibenclamide. NSC antagonists are disclosed as useful in the treatment of...
Invention Formulations and methods for lyophilization and lyophilates provided thereby. The present inventi...
2017 Invention Methods of medical treatment with sur1-trpm4 channel inhibitors. A method of treating or preventi...
Invention Methods of treating or preventing amyloid related imaging abnormalities associated with alzheimer...
2016 Invention Methods of reducing or preventing intimal damage caused by mechanical stimulation of endothelial ...
Invention Liquid formulations of compounds active at sulfonylurea receptors. The invention provides liquid ...
2013 Invention ++ activated atp-sensitive cation channels regulated by sur1 channels. NSC antagonists are disclo...
2011 Invention Methods of intravenous administration of glyburide and other drugs. Methods of administering glyb...
2009 Invention Liquid formulations of compounds active at sulfonylurea receptors. The invention provides liquid...
2007 Invention Treatment of alzheimer's disease using compounds that reduce the activity of non selective ca act...